
Finding rare diseases sooner
A rare disease can take years to name. We fund the practical work that shortens that wait, from better tests to clearer referral routes.
Find out moreA UK charity backing under-served health research
Info@duet.org.uk
A UK health research charity
Duet gives money and hands-on expertise to research, communication and education that commercial sponsors and government grants pass by — work on spotting rare diseases sooner, making medicines easier to live with, and explaining health clearly.
Registered UK charity · every grant decision answered within three weeks
3.5 million people
in the UK live with a rare condition
What we fund
Small, practical projects that can be delivered in a couple of years and would otherwise stall.

A rare disease can take years to name. We fund the practical work that shortens that wait, from better tests to clearer referral routes.
Find out more
Medicines only work if people can keep taking them. We support research into side effects and how they can be prevented, spotted and managed.
Find out more
Good science is wasted if nobody can understand it. We fund communication and education that helps the public, patients and clinicians make sense of the evidence.
Find out more
Our story
Mike and Julie Matthews spent twenty-five years building a drug development company. Having sold most of it, they set up Duet to work on the questions they had watched go unanswered — not because they didn't matter, but because there was no commercial return in them.
Duet brings their experience, expertise and network of scientific and medical contacts to projects that need all three, alongside the funding.
Read why Duet existsHow Duet works
Every project we back follows the same route. It is short, so researchers spend their time on the work rather than on paperwork.
A clinician, researcher or patient group tells us about a question nobody is funding — often a rare condition or a side effect people live with and rarely mention.
A single form describes the project, the people and the cost. No lengthy bid writing, no consultants, no application fee.
Our trustees read every application themselves, with twenty-five years of drug development experience behind the decision. You get a plain answer either way.
Money goes straight to the project — laboratory time, study nurses, analysis or writing — and never into overheads.
We keep in touch with short, practical reviews so problems get solved early instead of at the end.
Results are published openly and rewritten in plain English for patients, families and clinicians, because research nobody understands changes nothing.
Running a project that fits? The application is one form and you will have an answer within three weeks.
At a glance

We are small on purpose. That means we can say yes to a pilot study, a diagnostic test that needs validating, or a training programme, within weeks rather than months.
Guides to rare diseases, medicines and health research, written in everyday English.
Thinking of donating?
Five plain-English steps: how you give, why your gift reaches us in full, how we choose projects, and how we tell you what your money achieved.
Duet is funded by our founders and by people who believe useful research should not stall for want of a modest amount of money. Every gift goes into projects.
Newsletter
A short email a few times a year: the research we have funded, the people it reached, and the questions still waiting for an answer.
We will only email you about Duet's work. You can unsubscribe at any time, and we never share your details with anyone else.
14 July 2026
Three small projects — a faster diagnostic pilot, a side-effects clinic study and a schools programme — will share our first round of funding.
2 May 2026
After twenty-five years in drug development, our founders explain the questions that kept coming back to them.
19 March 2026
We brought together patients, pharmacists and researchers to talk honestly about medicines information. Here is what we heard.
Running a project that needs funding? Apply for a grant — one short form, answered within three weeks.